Gene Therapy for Pyruvate Kinase Deficiency (PKD)

Clinical trial NCT04105166 · COMPLETED

Trial details

NCT number: NCT04105166
Sponsor: Rocket Pharmaceuticals Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pyruvate Kinase Deficiency

Start date: 2020-07-06
Primary completion: 2025-06-09
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.